TL

Trevor Lockett

Dr Lockett is a molecular biologist and has over 30 years of research experience, predominantly at the CSIRO, Trevor has led large, multidisciplinary research efforts in the areas of prostate cancer gene therapy, colorectal cancer prevention and the promotion of gastrointestinal health.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RHY
RHY
31/07/241,678,3001,291,000193,650N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RHY
RHY
31/07/24
Expiry
252,000$0.053$13,356Options expired
RHY
RHY
21/03/24
Issued
387,300$0.100$38,730Rights issue
RHY
RHY
21/03/24
Issued
193,650$0.100$19,365Rights issue
RHY
RHY
08/08/23
Buy
1,125,000$0.200$225,000Exercise of options
RHY
RHY
08/08/23
Exercise
1,125,000$0.200$225,000Exercise of options